Erratum: Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections (European Radiology 10.1007/s00330-006-0357-4);Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections

European Radiology

Volumn 16, Issue 12, 2006, Pages 2712-2720

  Elmståhl, Barbara ^a   Nyman, Ulf ^b   Leander, Peter ^a   Chai, Chun Ming ^a   Golman, Klaes ^c   Björk, Jonas ^a   Almén, Torsten ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Lasarettet Trelleborg ^*  (Sweden)

^c BIACORE AB   (Sweden)

Author keywords

Angiography; Computed tomography; Contrast media; Gadolinium; Osmolality; Renal impairment

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; IODINE; IOHEXOL; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; GLOMERULUS FILTRATION RATE; INJECTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; NEPHROTOXICITY; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; RENAL ARTERY; SWINE;

EID: 33847730050     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0445-5     Document Type: Erratum

References (47)

1. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD (1998) Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement. Kidney Int 53:503-507
2. Spinosa DJ, Matsumoto AH, Hagspiel KD, Angle JF, Hartwell GD (1999) Gadolinium-based contrast agents in angiography and interventional radiology. AJR Am J Roentgenol 173:1403-1409
3. Sarkis A, Badaoui G, Azar R, Sleilaty G, Bassil R, Jebara VA (2003) Gadolinium-enhanced coronary angiography in patients with impaired renal function. Am J Cardiol 91:974-975
4. Ailawadi G, Stanley JC, Williams DM, Dimick JB, Henke PK, Upchurch GR Jr (2003) Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 37:346-352
5. Strunk HM, Schild H (2004) Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol 14:1055-1062
6. Erly WK, Zaetta J, Borders GT et al (2000) Gadopentetate dimeglumine as a contrast agent in common carotid arteriography. AJNR Am J Neuroradiol 21:964-967
7. Chryssidis S, Davies RP, Tie ML (2002) Gadolinium-enhanced computed tomographic aortography. Australas Radiol 46:97-100
8. Rémy-Jardin M, Dequiedt P, Ertzbischoff O et al (2005) Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: Preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 235:819-826
9. Nyman U, Elmståhl B, Leander P, Nilsson M, Golman K, Almén T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital substraction angiography in patients with azotemia? Radiology 223:311-318
10. Elmståhl B (2006) Are gadolinium contrast media really less nephrotoxic than iodine agents in radiographic examinations? A comparison in relation to their ability to attenuate X-rays in a pig model. In: Lund University Faculty of Medicine. Doctoral Dissertation Series 2006:9, Lund, Sweden
11. Spinosa DJ, Matsumoto AH, Angle JF et al (1998) Gadolinium-based contrast and carbon dioxide angiography to evaluate renal transplants for vascular causes of renal insufficiency and accelerated hypertension. J Vasc Interv Radiol 9:909-916
12. Morcos SK (1999) Contrast medium-induced nephrotoxicity. In: Dawson P, Cosgrove DO, Grainger RG (eds) Textbook of contrast media. Isis Medical Mediad, Oxford pp 135-148
13. Heyman SN, Reichman J, Brezis M (1999) Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia. Invest Radiol 34:685-691
14. Garber GL, Read RC (1961) Red cell factor in renal damage from hypertonic solutions. Proc Soc Exp Biol Med 107:472-475
15. Katzberg RW, Schulman G, Meggs LG, Caldicott WJ, Damiano MM, Hollenberg NK (1983) Mechanism of the renal response to contrast medium in dogs. Decrease in renal function due to hypertonicity. Invest Radiol 18:74-80
16. Morris TW, Katzberg RW, Fischer HW (1978) A comparison of the hemodynamic responses to metrizamide and meglumine/sodium diatrizoate in canine renal angiography. Invest Radiol 13:74-78
17. Törnquist C, Almén T, Golman K, Holtås S, (1984) Renal function following nephroangiography with diatriozoate Effects of saline, mannitol and diatrizoate on renal blood flow, glomerular permeability and filttration rate and diuresis in dogs. Acta Radiol 25:343-350
18. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: A consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602-1613
19. Grainger RG, Thomas AMK (1999) History of the development of radiological contrast media (1985-1996). In: Dawson P Cosgrove DO, Grainger RG (eds) Textbook of contrast media. Isis Medical Media, Oxford, pp 3-14
20. Elmståhl B, Nyman U, Leander P, Chai Ch-M, Frennby B, Almén T (2004) Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: An experimental study in pigs. Acad Radiol 11:1219-1228
21. de Haën C, Morisetti A, Bertani F, Tirone P (1994) The factor time in acute intravenous toxicity studies of contrast media. Invest Radiol 29 (Suppl 2):S108-S110
22. Weinmann HJ (1999) Gadolinium chelates: Physico-chemical properties, formulation and toxicology. In: Dawson P Cosgrove DO, Grainger RG (eds) Textbook of contrast media. Isis Medical Media, Oxford, pp 297-318
23. Almén T, Frennby B, Sterner G (1999) Trends in contrast media. Determination of glomerular filtration rate with contrast media. In: Thomsen HS, Muller RN, Mattrey RF (eds) Medical radiology. Diagnostic imaging and radiation oncology. Springer, Berlin Heidelberg New York, pp 81-94
24. Greenblatt DJ, Shader RI (1985) Pharmacokinetics in clinical practice. W.B. Saunders, Philadelphia, pp 1-40
25. Dean RE, Andrew JH, Read RC (1964) The red cell factor in renal damage from angiographic media; perfusion studies of the in situ canine kidney with cellular and acellular perfusates. JAMA 187:27-31
26. Katzberg RW, Morris TW, Burgener FA, Kamm DE, Fischer HW (1977) Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 12:381-388
27. Törnquist C, Almén T, Golman K, Holtas S (1985) Renal function following nephroangiography with metrizamide and iohexol. Effects on renal blood flow, glomerular permeability and filtration rate and diuresis in dogs. Acta Radiol Diagn (Stockh) 26:483-489
28. Deray G, Baumelou B, Martinez F, Brillet G, Jacobs C (1991) Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney. Clin Nephrol 36:93-96
29. Lund G, Einzig S, Rysavy J et al (1984) Role of ischemia in contrast-induced renal damage: An experimental study. Circulation 69:783-789
30. Aspelin P (1979) Effect of ionic and non-ionic contrast media on red cell deformability in vitro. Acta Radiol 20:1-11
31. Aspelin P, Nilsson PE, Schmid-Schonbein H, Schroder S, Simon R (1987) Effect of four non-ionic contrast media on red blood cells in vitro. III. Deformability. Acta Radiol Suppl 370:89-91
32. Almén T, Bergentz S-E, Törnquist K, Öystese B (1985) Selective nephroangiography in the dog causing renal plateletaggregation and irregutar nephrographic phase. Acta Radiol 26:627-634
33. Morcos SK, Brown PW, Oldroyd S, el Nahas AM, Haylor J (1995) Relationship between the diuretic effect of radiocontrast media and their ability to increase renal vascular resistance. Br J Radiol 68:850-853
34. Katzberg RW (1997) Urography into the 21st century: New contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204:297-312
35. Barrett BJ (1994) Contrast nephrotoxicity. J Am Soc Nephrol 5:125-137
36. Hardiek K, Katholi RE, Ramkumar V, Deitrick C (2001) Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 280:F61-F70
37. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M (2005) Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 235:843-849
38. Thomsen HS (2004) Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14:1654-1656
39. Thomsen HS, Almén T, Morcos SK (2002) Contrast Medai Safety Committee of The European Society of Urogenital Radiology (ESUR). Gadolinium-containing contrast media for radiographic examinations: A position paper. Eur Radiol 12:2600-2605
40. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178
41. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261
42. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499
43. Olsson B, Aulie Ö, Sveen K, Andrew E (1983) Human pharmacokinetics of iohexol a new nonionic contrast medium. Invest Radiol 18:177-182
44. Weinmann HJ, Laniado M, Mutzel W (1984) Pharmacokinetics of GdDTPA/ dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16:167-172
45. Van Wagoner M, Worah D (1993) Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent. Invest Radiol 28(Suppl 1):S44-S48
46. Terris JM (1985) Swine as a model in renal physiology and nephrology: An overview. Swine in biomedical research. In: Tumbleson, ME (ed) Swine in Biomedical Research, Vol. II, pp 1673-1690
47. Idée JM, Bonnemain B (1996) Reliability of experimental models of iodinated contrast media-induced acute renal failure. From methodological considerations to pathophysiology. Invest Radiol 31:230-241